Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events

PURPOSE: To capture UK societal health utility values for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and the disutility associated with treatment-related adverse events (AEs) to inform future cost–utility analyses. METHODS: A literature review, and patient and clinical expert int...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Qual Life Res
Auteurs principaux: Hall, F., de Freitas, H. M., Kerr, C., Ito, T., Nafees, B., Lloyd, A. J., Penton, J., Hadi, M., Lanar, S., Pham, T. P.
Format: Artigo
Langue:Inglês
Publié: Springer International Publishing 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6470112/
https://ncbi.nlm.nih.gov/pubmed/30767088
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11136-019-02117-9
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires